Home » Newsletters » BioWorld Science

BioWorld Science

April 7, 2005

View Archived Issues

Serotonin 5-HT7 receptor as a target for depression and other psychiatric diseases

Dendritic cell-targeted immunosuppressive actions of JM-34

Antipsychotic efficacy of bifeprunox mesilate

Cytos Biotechnology and Medarex expand collaboration

BioTie and sanofi-aventis to negotiate extension of agreement to develop oral heparin-like product

Halozyme files an NDA for Enhanze SC

Osiris cleared to begin stem cell trial for knee repair

Sepracor to launch Lunesta

Treatment begins in phase III study of tolevamer in CDAD

Phase III trial completed for Bio-E-Gel

Acorda launches Zanaflex Capsules

Novel PAR-2 antagonists presented by Kowa

Nuvelo and Kirin to develop NU-206

T-817MA alleviates oxidative stress in rat cortical neurons

Ligand earns milestone from TAP's IND filing

Recent Roche patents describe therapeutic agents for genitourinary disorders

Novel antiarthritic agents imparted by Cellular Genomics

New treatments for cardiovascular disorders claimed in recent patent literature

Japanese sales release of Zione Injection products

Peptide YY3-36 reduces food intake through taste aversion

Janus files IND for JA-001

Adoptive cell transfer demonstrates activity in metastatic melanoma patients

ATPase studied in new phase II trial

Curis and Genentech form second major collaboration

Phase III study of VP-002 for central precocious puberty completes enrollment

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 6, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...
Serotonin receptor modulators for the treatment of OUD
BioWorld Science
Opioid use disorder (OUD) causes high morbidity and mortality rates, with fentanyl driving unprecedented overdose rates. Researchers from the University of...
KLF15 shows potential as marker, target for cholangiocarcinoma
BioWorld Science
Researchers at the Biodonostia Health Research Institute reported on the role of KLF15 in cholangiocarcinogenesis and its potential as a therapeutic target in...